A new method was elaborated for examination in vivo of the synalbumin insulin antagonist. It was shown that the glucose concentration of incubated liver homogenates prepared from untreated rats increased with time. Previous intravenous insulin administration prevented this increase. If insulin was injected together with albumin prepared from the serum of diabetic patients, this effect of insulin was antagonized.
Introduction
Several workers have examined the effects in vivo of Vallanee-Owen's Synalbumin insulin antagonist [11, 12] . Jervell [6] using the intraperitoneal technique of Rafaelson et al. [10] showed that this Synalbumin antagonist opposed insulin action in vivo on the synthesis of glycogen in rat diaphragm muscle. These results were confirmed with intravenous administration of the Synalbumin, prepared by the trichloroacetie acid-ethanol method of Debro or by the Fernandez method [7] . However, when albumin previously shown to be antagonistic to insulin in vitro was infused for three hours into the femoral vein of lightly anaesthetized rats, no antagonism to insulin nor any diabetogenic effect could be demonstrated [2] .
A new method has been elaborated for the examination in vivo of the Synalbumin insulin antagonist. In this new method the effect of insulin was estimated by its inhibitory action on glycogeno]ysis in the liver homogenate, and SynMbumin could be tested for its insulin antagonistic effect.
Material and Methods
Albumin was prepared from fresh serum of fasting healthy subjects and of fasting diabetic patients by the method of Fernandez et al. [4] . Ordinarily, single preparations of albumin were used, although in some experiments two albumin samples were pooled in order to provide sufficient protein.
80 wistar rats of both sexes weighing 100--120 g were used. Eight animals were investigated in any one experiment, two in each group. Ten sets of experiments were done. The non-starving, unanaesthetized rats were injected in the tail vein.
Group I served as controls and received per 100 g body weight 2.5ml of Krebs-bicarbonate buffer solution (KRb).
Group II received per 100 g body weight 2.5 ml KRb and 0.4 units of crystalline insulin (Kgbs Gy6gyszerhrugys Budapest, Hungary).
Group III received per 100 g body weight 2.5 ml XRb, 0.4 units crystalline insulin, and 250 mg albumin prepared from the serum of normal subjects.
Group IV received per 100 g body weight 2.5 ml KRb, 0.4 units crystalline insulin, and 250 mg albumin prepared from the serum of diabetic patients.
This gives at the time of the injection a human albumin concentration of 3.8g per 100ml in the plasma of the rat. The concentration of the total blood volume would be 2.8 g per 100 ml.
45 rain after the injection, the rats were ldlled with a blow on the head. The blood sugar before the injection and that before killing were determined using the Somogyi-Nelson method [9] . The liver was taken out quickly, and placed in cold KRb for 10 rain. 2.5 g of the liver was then homogenized for 2 rain in 12 ml of cold Kl~b using a Potter homogenizer. The homogenate was centrifuged at 2000rev/min for 5 rain. The supernatant fluid was incubated in a Warburg apparatus at 37.3~ with a shaking frequency of 20/rain. Samples for glucose determination were taken at 0, 150 and 300 rain of incubation. The glucose concentration was determined by the method of Somogyi-
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Nelson [9] . At the same time the glycogen concentration of the homogenate was determined by the method of Good-Kramer-Somogyi [5] .
All albumin samples were tested at a concentration of 1.25 per cent for insulin antagonism in vitro [11] , those from diabetic patients being antagonistic, those from normal subjects non-antagonistic.
Results
The results of the investigations are shown in the following tables. It can be seen that there were no significant differences in the blood sugar concentrations of the different groups before the injection of this amount of insulin and 45 minutes later, before killing. 
Discussion
Insulin antagonistic effect of albumin prepared from the serum of diabetic patients was examined with a new method. The serum albumin samples were prepared by the Fernandez method, which did not involve dialysis and so occasional artefacts of the Visking tubing did not influence the results [8] . The problem of these possible artefacts, which was later discussed by Ensinck et al. [3] , can be eliminated by using this method of albumin preparation. The increase of glucose concentration in the liver homogenate was caused by the glycogenolysis, and it could be prevented by previous administration of insulin to the rat. The amount of insulin given did not cause a significant fall in the blood sugar of the rats [1] , but it was enough to reduce the glycogenolysis in the liver homogenate during the incubation period. With this method it could be shown that intravenous administration of albumin prepared from the serum of diabetic patients inhibited this effect of insulin. According to the results, the method described above can be used for the determination of Synalbumin. On the other hand, it may also prove an activity of Synalbumin in rive.
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